Kanzaki Masato, Takagi Ryo, Isaka Tamami, Yamato Masayuki
1 Department of Surgery I, Tokyo Women's Medical University, School of Medicine, Tokyo, Japan.
2 Institute of Advanced Biomedical Engineering and Science, Tokyo Women's Medical University, School of Medicine, Tokyo, Japan.
Biopreserv Biobank. 2019 Apr;17(2):163-170. doi: 10.1089/bio.2018.0105. Epub 2019 Feb 1.
During pulmonary resections, removal of visceral pleura is frequently required, resulting in lung air leakage (LAL) and bleeding. Especially persistent LAL after pulmonary surgery has negative consequences. Current surgical procedures are ineffective in closing these visceral pleural injuries. Previously, the authors' laboratory has developed a novel and effective LAL sealant using tissue-engineered cell sheets harvested from temperature-responsive culture dishes. The clinical application of fresh fibroblast sheets (FSs) is limited by several problems related to the cell culture period, mass production, preservation, and transportation. Therefore, cryopreservation of FSs and feasibility of off-the-shelf FSs for repairing visceral pleural defects were investigated. Over 3 to 6 months, harvested skin-derived FSs in Dulbecco's modified Eagle's medium supplemented with 10% dimethyl sulfoxide were stored in an atmosphere of liquid nitrogen. The amounts of cytokines (basic fibroblast growth factor [bFGF] and vascular endothelial growth factor) released from frozen-thawed FSs were determined. bFGF levels were significantly elevated in frozen-thawed FSs compared with fresh FSs. After a visceral pleural injury model was created, a frozen-thawed skin-derived FS was transplanted directly to the defect. One month after transplantation, the frozen-thawed FS remained on the pleural surface, resulting in permanent closure, suggesting that cells in the off-the-shelf FS had the ability to proliferate and release various cytokines. Frozen-thawed FSs were useful for closing LALs during pulmonary surgery as an off-the-shelf technique and would be used as a pleural substitute.
在肺切除术中,常常需要切除脏胸膜,这会导致肺漏气(LAL)和出血。尤其是肺手术后持续的LAL会产生负面后果。目前的外科手术方法在闭合这些脏胸膜损伤方面效果不佳。此前,作者所在实验室利用从温度响应培养皿中收获的组织工程细胞片开发出了一种新型有效的LAL密封剂。新鲜成纤维细胞片(FSs)的临床应用受到与细胞培养周期、大规模生产、保存及运输相关的几个问题的限制。因此,研究了FSs的冷冻保存以及即用型FSs修复脏胸膜缺损的可行性。在3至6个月的时间里,将收获的皮肤来源的FSs置于补充有10%二甲基亚砜的杜氏改良 Eagle培养基中,保存在液氮环境中。测定了冻融后FSs释放的细胞因子(碱性成纤维细胞生长因子[bFGF]和血管内皮生长因子)的量。与新鲜FSs相比,冻融后FSs中的bFGF水平显著升高。在建立脏胸膜损伤模型后,将冻融的皮肤来源的FS直接移植到缺损处。移植1个月后,冻融的FS仍留在胸膜表面,并实现了永久性闭合,这表明即用型FS中的细胞具有增殖和释放各种细胞因子的能力。冻融的FSs作为一种即用型技术,在肺手术中用于闭合LAL是有用的,并将用作胸膜替代物。